Once a stable dose is established, trough concentrations should be reviewed at least every 3 months. The therapeutic range will vary based on the use / indication and assay used for Rapamune (sirolimus). Refer to institutional / hospital protocols for target sirolimus trough concentrations. Therapeutic drug monitoring is recommended for all patients receiving sirolimus.